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    Mind-altering drugs, especially plants, have fascinated human and always occupied man’s attention 
.Among the plants used by humans, those able to alter the mind and the mood have drawn special 
consideration. Actually, due to their amazing effects, these drugs, have occupied much of the researchers’ 
time and efforts towards attempts to understand their mechanism, and, hence, to understand human thoughts, 
behavior, cognitive aspects, sensations and etc. The fact is plants could have beneficial properties to treat 
mental disease and have some effects on cognitive function. Now we know that plants by originating 
directly from nature are not less toxic than synthetic drugs. The manner of poisoning with plants can be 
divided into unintentional or intentional ingestion of plant material and substance abuse. This review article 
deals with β-carboline, which has effect on CNS. 
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INTRODUCTION 
    β-carbolineis a part of the indole 
alkaloidsgroup, and it’spyridine ring is fused to an 
indole skeleton. The structure of β-carbolineis 
similar to tryptamine[1]. A number of 
tremorogenic β-carboline alkaloids for example 
harmane (HA; 1-methyl-β-carboline ), 9H-pyrido 
[3, 4-β] indole (norharmane) and Harmine (7-
methoxy-1-methyl-9H-pyrido[3, 4-b]indole)are 
present in the food chain(figure 1). They have 
been found in plant-derived beverages, common 
plant-derived foodstuffs (rice, wheat, corn, 
mushrooms, barley, soybeans, vinegarand 
grapes), and plant-derived inhaled substances 
such as tobacco[2].The β-carbolines harmane, 
norharmane and harmine, first isolated in 
Peganum harmala, and related alkaloids are 
distributed in medicinal plants and exist 
inmammalian brain tissue, liver, blood plasma, 
heart andkidney. Since, high plasma levels of 
these compounds can befound in substance 
abusers and in some diseasessuch as Parkinson, 
they are assumed to have a role in the 
pathophysiologyof different typesof CNS 
disorders. β-carbolinesnot only have some effects 
on CNS, but also on some other organs in the 
humans.So they exhibit variety of 
psychopharmacological, biochemical, and 
behavioral effects in animals and humans.For 
exampleharmine(7-methoxy-1-methyl-9H-
pyrido[3, 4-b]indole)which is a tricyclic β-
carbolinealkaloid, hasmany traditional and 
pharmacological uses such as antimicrobial, anti-




Figure 1. Schematic representation of the chemical structure of 9H-pyrido [3, 4-β] indole (norharmane), HA; 1-methyl-β-carboline 
(harmane), and 7-methoxy-1-methyl-9H-pyrido[3, 4-b]indole (harmine) 
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Behavioral effects of harmine in rodents have been 
investigated. Effect of harmine on animal behavior 
was assessed in the forced swimming and open-
field tests, and the results showed harmine reduced 
immobility time and increased climbing and 
swimming time, compared to saline group. 
Harmine showed beneficial effects on naloxone-
precipitated morphine withdrawal syndrome in 
morphine-dependent rats. Harmine stimulates the 
central nervous system by inhibiting the 
metabolism of amine neurotransmitters .Harmine 
stimulates dopamine release, provingits usagein the 
treatment of brain disorders. 
 Neurotransmitters are endogenous chemicals that 
transmit signals from a neuron to a target cell 
across a synapse, such as Dopamine, GABA 
andSerotonin.The β-carbolines havebeen shown to 
bind to a variety of different targets including 
monoamine oxidase A and B (MAOA and 
MAOB), benzodiazepine, imidazoline, dopamine, 
histamine (under publication) and5-
hydroxytryptamine (5-HT) receptors[3, 4]. 
Following monoamine oxidase (MAO) A or B 
inhibition β-carbolines increase the level of 
monoamines[5].Also theyincrease the extracellular 
dopamine, norepinephrine, and 5-HT levels in 
differentbrain regions via inhibition of monoamine 
reuptake[6].As described above biochemical 
studies have revealed β -carbolines' several actions, 
for instancebinding to benzodiazepine and opiate 
receptors inhibition ofMAOA, competitive 
inhibition of 5-HT uptake, general inhibition of 
Na+ dependent transports and action on dopamine 
receptors, which may participate in a changeable 
degree in the actions of different types of β-
carbolines.  
 
Effect on Seizures 
    Benzodiazepines and GABAA receptor agonists 
have a well-known anticonvulsive effect and are 
routinely used for antiepileptic treatment, while 
inverse agonist β -carbolines are convulsant or 
proconvulsant agents. β-carbolinesact on the 
benzodiazepine site of the GABAA receptor. Some 
of them, such as harmalinehave a systematic 
agonist action, something likethe action of 
benzodiazepine agonists.  
The others have an inverse agonist action[7].These 
inverse agonist β-carbolines are important for 
analyzing the involvement of the GABAA receptor 
complexin many behavioral conditions. For 
example, methyl-6, 7-dimethoxy-4-ethyl-beta-
carboline-3-carboxylate (DMCM)is a powerful 
convulsant[8].Others, called “proconvulsants”, 
produce no spontaneous convulsive effect, but 
potentiate seizures induced by other compounds 
[9]. This effect has been studiedwithmethyl β-
carboline -3-carboxylate (β -CCM), which is 
convulsive or proconvulsive in rats[10]and mice 
[11]. The effects can be compensatedbyan 
antagonist, such as flumazenil. On the other hand, 
in some studies, flumazenil at very low doses has 
seen to potentiate the anticonvulsive effect of 
benzodiazepines, which means that it has a partial 
agonist effect.Betweenthe different inverse 
agonist β-carbolines, β-CCM is usually used for 
experimental research. 
 
Effect on Anxiety 
    Anxiety defined as the response of a subject to 
afulmination that may impair the homeostasis. 
This canincludetwo parameters: physiological 
(increase in blood pressure, heart rate,…) or 
behavioral (inhibition of ongoing behaviors, 
scanning, avoidance of the source of danger, ...). 
Benzodiazepines haveanxiolytic effects in both 
humans[12] and animals[13].β-carbolinesproduce 
anxiogenic effects in humans and animals. Human 
studies[14], found evidence of an anxiogenic 
effect ofsome β-carbolinein healthy volunteers. 
Also animal studies have demonstratedthat 
someβ-carbolineshave an anxiogenic effect on 
rodents[15].β-carbolinesbind with high affinity to 
benzodiazepine site of theGABAA receptors as 
inverse agonists; some possess anxiogenic 
character and others act asanxiolytic, depending 
on the dose [16]. In comparison, it should be 
mentioned that convulsants not acting on the 
benzodiazepine site, e.g., picrotoxin, have clear 
anxiogenic effects on mice[17], at doses lower 
than convulsive doses.So we can understand 
thatthe efficient dose for producing anxiogenic 
effects is lower than the dose required for 
inducing convulsions.  
 
Effect on depression 
    As we mentioned above β-carbolines bind to 
other neurotransmitter receptors in the brain, 
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including 5-hydroxytryptamine (5-HT), dopamine 
receptors also imipramine/citalopram recognition 
site [18].Also we know that thesealkaloids increase 
the extracellular norepinephrine, dopamine and 5-
HT levels in several brain regions with inhibitory 
effect on monoamine reuptake systems.These 
increase the levels of monoamines after 
monoamine oxidase (MAO)A or B 
inhibition.These results suggest a possible role of 
β-carbolines in control of depression. The β-
carbolines harmane, norharmane and harmine 
which are present in the brain, may be synthesized 
by condensation reaction of tryptamine with 
acetaldehyde or pyruvic acid [19].Behavioral 
effectsof β-carbolines and benzodiazepines are 
antagonized by flumazenil[20].One study shows 
that, flumazenil at a dose ineffective per se on the 
duration of immobility, antagonized the 
antidepressant-like effects of β-carbolines.It 
provides some evidence that β-carbolines induce 
an antidepressant-like effect through stimulation of 
the benzodiazepine receptor in an inverse way[21]. 
β-carbolines also display high affinity for I2-
imidazoline receptors [22].These receptors hasbeen 
implicated in depression[23]. In depression, the 
levels of I2-imidazoline binding sites are changed. 
The antidepressant-like effects of the I2-ligands 
have been reported in the animal forced swim test. 
In conclusion, β-carbolines harmane, norharmane 
and harmine have an antidepressant-like effect in 
the forced swim test. This effect seems to be 
induced by an inverse-agonistic mechanism located 
in the benzodiazepine receptors. 
 
Effect on Memory 
    Memory is the process in which information is 
encoded, stored, and retrieved. Encoding allows 
information to reach our senses in the forms of 
chemical and physical stimuli.Storage is 
maintaining theinformation over periods of time. 
Finally the third process is the retrieval of 
theinformation that has been 
stored.Benzodiazepines are often said to have 
“amnesic” effects in humans. It hasbeen reported 
that benzodiazepines induced marked anterograde 
amnesia after injection [24]. Sincethen, several 
amnesic effects of benzodiazepines have been 
describedin humans and animals. However, in 
different learning situations[25-27][28, 
29]flumazenil has effects similar to the effects of 
an inverse agonist. 
β-carbolines, such as DMCM, have been shown to 
modify learning abilities in animals[30, 31] 
“Paradoxical” memory-enhancing effects ofβ-
carbolines have also been reported in some 
cases.Some researchers [26, 32] found that direct 
intracerebral injection of β -CCM (at extremely 
low doses: 3 µg/0.5 µl) injected into the nucleus 
basalismagnocellularis of the rat enhanced 
recognition in a two-trial recognition task. The 
nucleus basalismagnocellularis of the rat is the 
equivalent of the nucleus basalis of Meynert in 
humans, which has an important role in amnesic 
impairments observed in Alzheimer-type senile 
dementia[33].The role ofGABAergic neurons in 
this region, being involved in memory processes, 
offers new evidence for the designation of GABA 
in Alzheimer’s disease.  
Benzodiazepines andβ -CCM appear to act 
specifically on theacquisition (learning) phase of 
memory processing. There should be a 
physiological link between β -CCM–induced 
convulsions, β -CCM–induced anxious behavior, 
and β -CCM–induced learning processes, as β -
CCM, is convulsant at high doses, anxiogenic at 
moderate doses, and learningenhancing at very low 
doses.Therefore a link could be required between 
learning and mild anxiety, indicatingthat the 
“normal” state of thebrain for optimal learning 
would be a state of mild anxiety, and when anxiety 
levels are too high, there would be pathological 
problem, such asseizure[34].The limbic system, 
has been shown to be involved in seizuring[35], 
anxiety[36], and memory processing[37].In fact, 
these three processes have been associated with 
GABA receptors subunits. As mentioned before, β-
carboline s can act on CNS binding sites [38], for 
example5HT2 and 5HT1A receptors, imidazoline 
receptors, and NMDA receptors.β-
carbolinesinhibitenzymes such asmonoamine 
oxidase A and, and inducible nitric oxide 
synthaseNOS).β-carbolines are relatedto decrease 
level of iNOS protein and NOS promoter activities 
in a concentration-dependent manner[39].Nitric 
oxide (NO) has an importantrole, as a second 
messenger, in the central and peripheral nervous 
systems. It takes part inspecific forms of long-term 
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Table 1. Some neurological effects of β-carbolines 
Seizures 
β-carbolines have convulsant or proconvulsant effects. Some of them , such as DMCM, are 
powerful convulsants, whereas some other compounds, such as Ro 15-4513 (a partial inverse 
agonist), FG 7142 and n-butyl beta carboline-3-carboxylate, have no spontaneous convulsive 
effect, but potentiate seizures induced by other compounds. 
Anxiety 
β-carbolines have anxiogenic effects in both animals and humans. Animal studying have shown 
that certain β-carbolines have an anxiogenic affect on monkeys and rodents.Humans studies , 
found evidence of an anxiogenic effect  of FG 7142(β-carbolines) in healthy human volunteers.  
Depression 
 β-carbolines bind to other neurotransmitter receptors in the brain, including 5-hydroxytryptamine 
(5-HT)and dopamine receptors .Also we know that these alkaloids increase the extracellular 
norepinephrine, dopamine and 5-HT levels in several brain regions with inhibitory effect on 
monoamine reuptake systemsThese results suggest a possible role of β-carbolines in control of 
depression. 
Memory 
Several β-carbolines have been shown to modify learning abilities in rodents(promnesic 
effects),but in some studies they bring memory impairment. Benzodiazepines and  beta-CCM 
appear to act specifically on the acquisition (learning) phase of memory processing. 
 
NO  is involved in central effects of some drugs 
like nicotine, morphine, cannabinoid, ethanol, 
lithium, and histamine.Furthermore, the 
hippocampus, which has a main role in learning 
and memory, is obligatory to mediate the 
expression of passive avoidance learning.Also 
several studies indicated that NO and 
harmane[41] are involved in hippocampus-
dependent learning and memory. Some 
neurological effects of β-carbolines are tabulated 
in table 1.  
CONCLUSION 
     In recent years, attention has been paid to the 
health promoting activity of plant foods and their 
active components. Although essential 
improvements in the quality control have been 
made, we should be more careful about the 
optimization of the extraction and separation 
procedures of these plants. Thus, further studies 
are needed to explore the hidden potential of β-
carbolines in treating various diseases.  
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